Back
Xeris Biopharma Holdings, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
XERS
Xeris Biopharma Holdings, Inc.
Last Price:
$6.11
Seasonality Move:
8.87%
7 Day Trial
ALL ACCESS PASS
$
7
Xeris Biopharma Holdings, Inc. Stock Forecast
-
Over the next 52 weeks, Xeris Biopharma Holdings, Inc. has on average historically risen by 13.7% based on the past 7 years of stock performance.
-
Xeris Biopharma Holdings, Inc. has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Xeris Biopharma Holdings, Inc. Stock Undervalued?The current Xeris Biopharma Holdings, Inc. [XERS] share price is $6.12. The Score for XERS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
XERS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Xeris Biopharma Holdings, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Xeris Biopharma Holdings, Inc. has on average historically risen by 13.7% based on the past 7 years of stock performance.
Xeris Biopharma Holdings, Inc. Stock Rating
Sell
43
Xeris Biopharma Holdings, Inc. (XERS)
is a Sell
Is Xeris Biopharma Holdings, Inc. overpriced?
-
Xeris Biopharma Holdings, Inc. has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Xeris Biopharma Holdings, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
xerispharma.com
52-Week Data
52-Week High:
10.08
52-Week Low:
3.59
Prediction Charts
Market Cap:
1B
Price in USD:
6.12
Volume:
5.9M
Beta:
1.27
Technical Analysis
SMA50:
7.21
SMA100:
7.60
SMA200:
6.82
52-Wk Change:
62.77%
Stock Predictions
-
Is Xeris Biopharma Holdings, Inc. stock public?Yes, Xeris Biopharma Holdings, Inc. is a publicly traded company.
-
What is the Xeris Biopharma Holdings, Inc. stock quote today?The Xeris Biopharma Holdings, Inc. stock price is 6.12 USD today.
-
How to buy Xeris Biopharma Holdings, Inc. stock online?You can buy Xeris Biopharma Holdings, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-9 | 7.00 | 6.96 | 7.06 | 6.86 |
| Feb-10 | 7.03 | 7.22 | 7.22 | 6.90 |
| Feb-11 | 7.22 | 6.91 | 7.26 | 6.87 |
| Feb-12 | 6.95 | 6.91 | 7.02 | 6.78 |
| Feb-13 | 6.94 | 6.82 | 7.10 | 6.80 |
| Feb-17 | 6.85 | 6.91 | 7.03 | 6.80 |
| Feb-18 | 6.84 | 7.03 | 7.07 | 6.80 |
| Feb-19 | 6.97 | 6.73 | 7.02 | 6.26 |
| Feb-20 | 6.69 | 6.61 | 6.77 | 6.51 |
| Feb-23 | 6.55 | 6.58 | 6.74 | 6.55 |
| Feb-24 | 6.59 | 6.68 | 6.69 | 6.57 |
| Feb-25 | 6.72 | 6.66 | 6.75 | 6.62 |
| Feb-26 | 6.70 | 6.74 | 6.77 | 6.44 |
| Feb-27 | 6.51 | 6.12 | 6.62 | 5.80 |
Xeris Biopharma Holdings, Inc. Earnings
Xeris Biopharma Holdings, Inc. Earnings Report: Per Share Xeris Biopharma Holdings, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Xeris Biopharma Holdings, Inc. Forecast Revenue Growth
Xeris Biopharma Holdings, Inc. Stock Analysis: Historical quarterly revenues per share for Xeris Biopharma Holdings, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.18 per share.
* Xeris Biopharma Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.